SEARCH

SEARCH BY CITATION

References

  • 1
    Pittenger MF, Mackay AM, Beck SC, et al . Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 1437.
  • 2
    Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryipreservation. J Cell Biochem. 1997; 64: 27894.
  • 3
    Horwitz ED, Prockop DJ, Fitzpatrick LA, et al . Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999; 5: 30913.
  • 4
    Chen SL, Fang WW, Ye F, et al . Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004; 94: 925.
  • 5
    Bang OY, Lee JS, Lee PH, et al . Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005; 57: 87482.
  • 6
    Ringden O, Uzunel M, Rasmusson I, et al . Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplant. 2006; 81: 13907.
  • 7
    Nakamura K, Ito Y, Kawano Y, et al . Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 2004; 11: 115564.
  • 8
    Studeny M, Marini FC, Dembinski JL, et al . Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst. 2004; 96: 1593603.
  • 9
    Eliopoulos N, Gagnon RF, Francois M, et al . Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure. J Am Soc Nephrol. 2006; 17: 157684.
  • 10
    Karnieli O, Izhar-Prato Y, Bulvik S, et al . Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic modification. Stem Cells. 2007; 25: 283744.
  • 11
    Gugala Z, Olmsted-Davis EA, Gannon FH, et al . Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type. Gene Ther. 2003; 10: 128996.
  • 12
    Zhang XS, Linkhart TA, Chen ST, et al . Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice. J Gene Med. 2004; 6: 415.
  • 13
    Gersbach CA, Le Doux JM, Guldberg RE, et al . Inducible regulation of Runx2-stimulated osteogenesis. Gene Ther. 2006; 13: 87382.
  • 14
    Sun L, Cui M, Wang Z, et al . Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction. Biochem Biophys Res Commun. 2007; 357: 77984.
  • 15
    Noort WA, Kruisselbrink AB, In’t Anker PS, et al . Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol. 2002; 30: 8708.
  • 16
    Park SK, Won JH, Kim HJ, et al . Co-transplantation of human mesenchymal stem cells promotes human cd34+ cells engraftment in a dose-dependent fashion in NOD/SCID mice. J Korean Med Sci. 2007; 22: 4129.
  • 17
    Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976; 4: 26774.
  • 18
    Mohyeddin-Bonab M, Alimoghaddam K, Talebian F, et al . Aging of mesenchymal stem cells in vitro. BMC Cell Biol. 2006; 7: 14.
  • 19
    Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al . Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000; 2: 47788.
  • 20
    De Bari C, Dell’Accio F, Luyten FP. Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum. 2001; 44: 8595.
  • 21
    Lee OK, Kuo TK, Chen WM, et al . Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood. 2004; 103: 166975.
  • 22
    De Bari C, Dell’Accio F, Tylzanowski P, et al . Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001; 44: 192842.
  • 23
    Tuli R, Tuli S, Nandi S, et al . Characterisation of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells. 2003; 21: 68193.
  • 24
    Boquest AC, Shahdadfar A, Fronsdal K, et al . Isolation and transcription profiling of purified uncultured human stromal stem cells: alternation of gene expression after in vitro cell culture. Mol Biol Cell. 2005; 16: 113141.
  • 25
    Polisetty N, Fatima A, Madhira SL, et al . Mesenchymal cells from limbal stroma of human eye. Mol Vis. 2008; 14: 43142.
  • 26
    In’t Anker PS, Scherion SA, Kleijburg-van der Keur C, et al . Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003; 102: 15489.
  • 27
    Martin J, Helm K, Ruegg P, et al . Adult lung side population cells have mesenchymal stem cell potential. Cytotherapy. 2008; 10: 14051.
  • 28
    Young HE, Steele TA, Bray RA, et al . Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec. 2001; 264: 5162.
  • 29
    Da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells. 2008; 26: 228799.
  • 30
    Dominici M, Le Blanc K, Mueller I, et al . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 3157.
  • 31
    Quirici N, Soligo D, Bossolasco P, et al . Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol. 2002; 30: 78391.
  • 32
    Anjos-Afonso F, Bonnet D. Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment. Blood. 2007; 109: 1298306.
  • 33
    Gang EJ, Bosnakovski D, Figueiredo CA, et al . SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood. 2007; 109: 174351.
  • 34
    Satija NK, Gurudutta GU, Sharma S, et al . Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cells Dev. 2007; 16: 723.
  • 35
    Reyes M, Lund T, Lenvik T, et al . Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. Blood. 2001; 98: 261525.
  • 36
    Pittenger MF, Marshak DR. Mesenchymal stem cells of human adult bone marrow. In: MarshakDR, GardnerRL, GottliebD, editors. Stem cell biology. New York : Cold Spring Harbor Laboratory Press; 2001, pp. 34973.
  • 37
    D’lppolito G, Diabira S, Howard GA, et al . Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci. 2004; 117: 297181.
  • 38
    Kucia M, Reca R, Campbell FR, et al . A population of very small embryonic-like (VSEL) CXCR4+ SSEA-1+ Oct-4+ stem cells identified in adult bone marrow. Leukemia. 2006; 20: 85769.
  • 39
    Kadivar M, Khatami S, Mortazavi Y, et al . In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun. 2006; 340: 63947.
  • 40
    Kang XQ, Zang WJ, Bao LJ, et al . Fibroblast growth factor-4 and hepatocyte growth factor induce differentiation of human umbilical cord blood-derived mesenchymal stem cells into hepatocytes. World J Gastroenterol. 2005; 11: 74615.
  • 41
    Hung SC, Chen H, Pan CY, et al . In vitro differentiation of size-sieved stem cells into electrically active neural cells. Stem Cells. 2002; 20: 5229.
  • 42
    Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multi-potent stromal cells (MSCs). The state of transdifferentiation and modes of tissue repair – current views. Stem Cells. 2007; 25: 2896902.
  • 43
    Terada N, Hamazaki T, Oka M, et al . Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002; 416: 5425.
  • 44
    Spees JL, Olson SD, Ylostalo J, et al . Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA. 2003; 100: 2397402.
  • 45
    Colter DC, Class R, DiGirolamo CM, et al . Rapid expansion of recycling stem cells in cultures of plastic adherent cells from human bone marrow. Proc Natl Acad Sci USA. 2000; 97: 32138.
  • 46
    Lazarus HM, Haynesworth SE, Gerson SL, et al . Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant. 1995; 16: 55764.
  • 47
    Koc ON, Gerson SL, Cooper BW, et al . Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000; 18: 30716.
  • 48
    Horwitz EW, Gordon PL, Koo WKK, et al . Isolated allogeneic bone marrow-derived mesenchymal stem cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA. 2002; 99: 89327.
  • 49
    Lataillade JJ, Doucet C, Bey E, et al . New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med. 2007; 2: 78594.
  • 50
    Le Blanc K, Tammik C, Rosendahl K, et al . HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003; 31: 8906.
  • 51
    Di Nicola M, Carlo-Stella C, Magni M, et al . Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002; 99: 383843.
  • 52
    Majumdar MK, Keane-Moore M, Buyaner D, et al . Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci. 2003; 10: 22841.
  • 53
    Ryan JM, Barry FP, Murphy JM, et al . Mesenchymal stem cells avoid allogeneic rejection. J Inflamm. 2005; 2: 8.
  • 54
    Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stem cells. Blood. 2007; 110: 3499506.
  • 55
    Le Blanc K, Rasmusson I, Sundberg B, et al . Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004; 363: 143941.
  • 56
    Koc ON, Day J, Nieder M, et al . Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002; 30: 21522.
  • 57
    Herrera MB, Bussolati B, Bruno S, et al . Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med. 2004; 14: 103541.
  • 58
    Chamberlain G, Fox J, Ashton B, et al . Concise review. Mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007; 25: 273949.
  • 59
    Stein JV, Nombela-Arrieta C. Chemokine control of lymphocyte trafficking: a general overview. Immunology. 2005; 116: 112.
  • 60
    Ruster B, Gottig S, Ludwig RJ, et al . Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood. 2006; 108: 393844.
  • 61
    Kinnaird T, Stabile E, Burnett MS, et al . Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation. 2004; 109: 15439.
  • 62
    Kinnaird T, Stabile E, Burnett MS, et al . Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res. 2004; 94: 67885.
  • 63
    Chen L, Tredget EE, Wu PY, et al . Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE. 2008; 3: e1886.
  • 64
    Nakanishi C, Yamagishi M, Yamahara K, et al . Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun. 2008; 374: 116.
  • 65
    Oettgen P. Cardiac stem cell therapy. Need for optimization of efficiency and safety monitoring. Circulation. 2006; 114: 3538.
  • 66
    Choumerianou DM, Dimitriou H, Kalmanti M. Stem cells: promises versus limitations. Tissue Eng Part B Rev. 2008; 14: 5360.
  • 67
    Hess DC, Borlongan CV. Stem cells and neurological diseases. Cell Prolif. 2008; 41(Suppl 1): 94114.
  • 68
    Segers VFM, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008; 451: 93742.
  • 69
    Kuang S, Rudnicki MA. The emerging biology of satellite cells and their therapeutic potential. Trends Mol Med. 2008; 14: 8291.
  • 70
    Ortiz LA, Gambelli F, McBride C, et al . Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA. 2003; 100: 840711.
  • 71
    Rojas M, Xu J, Woods CR, et al . Bone marrow-derived mesenchymal stem cells in the repair of the injured lung. Am J Respir Cell Mol Biol. 2005; 33: 14552.
  • 72
    Ortiz LA, DuTreil M, Fattman C, et al . Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA. 2007; 104: 110027.
  • 73
    Sasaki M, Abe R, Fujita Y, et al . Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008; 180: 25817.
  • 74
    Wu Y, Chen L, Scott PG, et al . Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007; 25: 264859.
  • 75
    Li HH, Fu XB, Ouyang YS, et al . Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages. Cell Tissue Res. 2006; 14: 32535.
  • 76
    Schenk S, Mal N, Finan A, et al . Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells. 2007; 25: 24551.
  • 77
    Fu XB, Fang LJ, Li XK, et al . Enhanced wound-healing quality with bone marrow mesenchymal stem cells autografting after skin injury. Wound Rep Reg. 2006; 14: 32535.
  • 78
    Lee RH, Seo MJ, Reger RL, et al . Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/SCID mice. Proc Natl Acad Sci USA. 2006; 103: 1743843.
  • 79
    Gao X, Song L, Shen K, et al . Transplantation of bone marrow derived cells promotes pancreatic islet repair in diabetic mice. Biochem Biophys Res Commun. 2008; 371 1327.
  • 80
    Boumaza I, Srinivasan S, Witt WT, et al . Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia. J Autoimmun. 2009; 32: 3342.
  • 81
    Munoz JR, Stoutenger BR, Robinson AP, et al . Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA. 2005; 102: 181716.
  • 82
    Urbán VS, Kiss J, Kovács J, et al . Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells. 2008; 26: 24453.
  • 83
    Shi PA, Hematti P, Von Kalle C, et al . Genetic marking as an approach to study in vivo hematopoiesis: progress in the non-human primate model. Oncogene. 2002: 21: 327483.
  • 84
    Maitra B, Szekely E, Gjini K, et al . Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 2004; 33: 597604.
  • 85
    Le Blanc K, Ringden O. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005; 11: 32134.
  • 86
    Fliedner TM, Nothdirft W, Calvo W. The development of radiation late effects to the bone marrow after single and chronic exposure. Int J Radiat Biol Stud Phys Chem Med. 1986; 49: 3546.
  • 87
    Galotto M, Berisso G, Delfino L, et al . Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol. 1999; 27: 146066.
  • 88
    Madhusudhan T, Majumdar SS, Mukhopadhyay A. Degeneration of stroma reduces retention of homed cells in bone marrow of lethally irradiated mice. Stem Cell Dev. 2004; 13: 17382.
  • 89
    Bartholomew A, Sturgeon C, Siatskas M, et al . Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002; 30: 428.
  • 90
    Barbash IM, Chouraqui P, Baron J, et al . Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003; 108: 8638.
  • 91
    Mahmood A, Lu D, Lu M, et al . Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery. 2003; 53: 697702.
  • 92
    Mouiseddine M, François S, Semont A, et al . Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/severe combined immunodeficiency mouse model. Br J Radiol. 2007; 80 Spec No 1: S4955.
  • 93
    Devine SM, Cobbs C, Jennings M, et al . Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood. 2003; 101: 29993001.
  • 94
    Hofmann M, Wollert KC, Meyer GP, et al . Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005; 111: 2198202.
  • 95
    Rombouts WJ, Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia. 2003; 17: 16070.
  • 96
    Zhang M, Methot D, Poppa V, et al . Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol. 2001; 33: 90721.
  • 97
    Toma C, Pittenger MF, Cahill KS, et al . Human mesenchymal stem cell differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation. 2002; 105: 9398.
  • 98
    Pasha Z, Wang Y, Sheikh R, et al . Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res. 2008; 77: 13442.
  • 99
    Hu X, Yu SP, Fraser JL, et al . Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J Thorac Cardiovasc Surg. 2008; 135: 799808.
  • 100
    Rosova I, Dao M, Capoccia B, et al . Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells. 2008; 26: 217382.
  • 101
    Ip JE, Wu Y, Huang J, et al . Mesenchymal stem cells use integrinβ1 not CXC chemokine receptor 4 for myocardial migration and engraftment. Mol Biol Cell. 2007; 18: 287382.
  • 102
    Herrera MB, Bussolati B, Bruno S, et al . Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int. 2007; 72: 43044.
  • 103
    Shi M, Li J, Liao L, et al . Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica. 2007; 92: 897904.
  • 104
    Kumar S, Ponnazhagan S. Bone homing of mesenchymal stem cells by ectopic alpha 4 integrin expression. FASEB J. 2007; 21: 391727.
  • 105
    Ji JF, He BP, Dheen ST, et al . Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells. 2004; 22: 41527.
  • 106
    Breitbach M, Bostani T, Roell W, et al . Potential risks of bone marrow cell transplantation into infarcted hearts. Blood. 2007; 110: 13629.
  • 107
    Song L, Webb NE, Song Y, et al . Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells. 2006; 24: 170718.
  • 108
    Chang SC, Chuang HL, Chen YR, et al . Ex vivo gene therapy in autologous bone marrow stromal stem cells for tissue-engineered maxillofacial bone regeneration. Gene Ther. 2003; 10: 20139.
  • 109
    Noel D, Gazit D, Bouquet C, et al . Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells. Stem Cells. 2004; 22: 7485.
  • 110
    Zhao M, Zhao Z, Koh JT, et al . Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4 and 7. J Cell Biochem. 2005; 95: 116.
  • 111
    Franceschi RT. Biological approaches to bone regeneration by gene therapy. J Dent Res. 2005; 84: 1093103.
  • 112
    Gersbach CA, Le Doux JM, Guldberg RE, et al . Inducible regulation of Runx2-stimulated osteogenesis. Gene Ther. 2006; 13: 87382.
  • 113
    Chamberlain JR, Schwarze U, Wang PR, et al . Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science. 2004; 303: 1198201.
  • 114
    Goncalves MA, De Vries AA, Holkers M, et al . Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. Human Mol Genet. 2005; 15: 21321.
  • 115
    Li Y, Zhang R, Qiao H, et al . Generation of insulin-producing cells from PDX-1 gene-modified human mesenchymal stem cells. J Cell Physiol. 2007; 211: 3644.
  • 116
    Noiseux N, Gnecchi M, Lopez-Ilasaca M, et al . Mesenchymal stem cells overexpressing Akt dramatically repair infracted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther. 2006; 14: 84050.
  • 117
    Gnecchi M, He H, Liang OD, et al . Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med. 2005; 11: 3678.
  • 118
    Mirotsou M, Zhang Z, Deb A, et al . Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci USA. 2007; 104: 16438.
  • 119
    Kim SS, Yoo SW, Park TS, et al . Neural induction with neurogenin1 increases the therapeutic effects of mesenchymal stem cells in the ischemic brain. Stem Cells. 2008; 26: 221728.
  • 120
    Westenbroek RE, Merrick DK, Catterall WA. Differential subcellular localization of the RI and RII Na+ channel subtypes in central neurons. Neuron. 1989; 3: 695704.
  • 121
    Li Y, Chen J, Chen XG, et al . Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology. 2002; 59: 51423.
  • 122
    Chen J, Li Y, Katakowski M, et al . Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res. 2003; 73: 77886.
  • 123
    Cheng Z, Ou L, Zhou X, et al . Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther. 2008; 16: 5719.
  • 124
    Zhang D, Fan GC, Zhou X, et al . Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infracted myocardium. J Mol Cell Cardiol. 2008; 44: 28192.
  • 125
    Tang YL, Tang Y, Zhang YC, et al . Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol. 2005; 46: 133950.
  • 126
    Li W, Ma N, Ong LL, et al . Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells. 2007; 25: 211827.
  • 127
    Mangi AA, Noiseux N, Kong D, et al . Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med. 2003; 9: 1195201.
  • 128
    Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003; 4: 34658.
  • 129
    Park J, Ries J, Gelse K, et al . Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: a comparison of adenoviral vectors and liposomes. Gene Ther. 2003; 10: 108998.
  • 130
    Bartholomew A, Patil S, Mackay A, et al . Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Hum. Gene Ther. 2001; 12: 152741.
  • 131
    Campeau PM, Rafei M, Francois M, et al . Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients. Mol Ther. 2009; 17: 36972.
  • 132
    Burkus JK, Transfeldt EE, Kitchel SH, et al . Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine. 2002; 27: 2396408.
  • 133
    Fang J, Zhu YY, Smiley E, et al . Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci USA. 1996; 93: 57538.
  • 134
    Engler AJ, Sen S, Sweeney HL, et al . Matrix elasticity directs stem cell lineage specification. Cell. 2006; 126: 67789.
  • 135
    Curran JM, Chen R, Hunt JA. The guidance of human mesenchymal stem cell differentiation in vitro by controlled modifications to the cell substrate. Biomaterials. 2006; 27: 478393.
  • 136
    Vilquin JT, Rosset P. Mesenchymal stem cells in bone and cartilage repair: current status. Regen Med. 2006; 1: 589604.
  • 137
    Arinzeh TL, Peter SJ, Archambault MP, et al . Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am. 2003; 85-A: 192735.
  • 138
    Clark ERC. Microscopic observations on the growth of blood capillaries in the living mammal. Am J Anat. 1939; 64: 251301.
  • 139
    Cassell OCS, Hofer SOP, Morrison WA, et al . Vascularisation of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states. Br J Plastic Surg. 2002; 55: 60310.
  • 140
    Yang J, Zhou W, Zheng W, et al . Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology. 2007; 107: 1729.
  • 141
    Rouwkema J, De Boer J, Van Blitterswijk CA. Endothelial cells assembly into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng. 2006; 12: 268593.
  • 142
    Rouwkema J, Rivron NC, Van Blitterswijk CA. Vascularisation in tissue engineering. Trends Biotechnol. 2008; 26: 43441.
  • 143
    Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med. 1999; 5: 135964.
  • 144
    Kadivar M, Khatami S, Mortazavi Y, et al . In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem Biophys Res Commun. 2006; 340: 63947.
  • 145
    Amado LC, Saliaris AP, Schuleri KH, et al . Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA. 2005; 102: 114749.
  • 146
    Mohyeddin-Bonab M, Mohamad-Hassani MR, Alimoghaddam K, et al . Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction. Arch Iran Med. 2007; 10: 46773.
  • 147
    Tisato V, Naresh K, Girdlestone J, et al . Mesenchymal stem cells of cord blood origin are effective at preventing but not treating graft-versus-host disease. Leukemia. 2007; 21: 19929.
  • 148
    Ringden O, Uzunel M, Rasmusson I, et al . Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplant. 2006; 81: 13907.
  • 149
    Le Blanc K, Frassoni F, Ball L, et al .; Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008; 371: 157986.
  • 150
    Lazarus HM, Koc ON, Devine SM, et al . Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant. 2005; 11: 38998.
  • 151
    Ning H, Yand F, Jiang M, et al . The correlation between cotransplantation of MSC and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical trial. Leukemia. 2008; 22: 5939.
  • 152
    Quarto R, Mastrogiacomo M, Cancedda R, et al . Repair of large bone defects with the use of autologous bone marrow stromal cells. N Eng J Med. 2001; 344: 3856.
  • 153
    Gan Y, Dai K, Zhang P, et al . The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion. Biomaterials. 2008; 29: 397382.
  • 154
    Prockop DJ, Olson SD. Clinical trials with adult stem/progenitor cells for tissue repair: let’s not overlook some essential precautions. Blood. 2007; 109: 314751.
  • 155
    Miura M, Miura Y, Padilla-Nash HM, et al . Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells. 2006; 24: 1095103.
  • 156
    Rubio D, Garcia-Castro J, Martin MC, et al . Spontaneous human adult stem cell transformation. Cancer Res. 2005; 65: 30359.
  • 157
    Wagner W, Horn P, Castoldi M, et al . Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS ONE. 2008; 3: e2213.
  • 158
    Shibata KR, Aoyama T, Shima Y, et al . Expression of the p16INK4A gene is associated closely with senescence of human mesenchymal stem cells and is potentially silenced by DNA methylation during in vitro expansion. Stem Cells. 2007; 25: 237182.
  • 159
    Bianchi G, Banfi A, Mastrogiacomo M, et al . Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res. 2003; 287: 98105.
  • 160
    Ito T, Sawada R, Fujiwara Y, et al . FGF-2 suppresses cellular senescence of human mesenchymal stem cells by down-regulation of TGF-β2. Biochem Biophys Res Commun. 2007; 359: 10814.
  • 161
    Simonsen JL, Rosada C, Serakinci N, et al . Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol. 2002; 20: 5926.
  • 162
    Miura M, Miura Y, Padilla-Nash HM, et al . Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells. 2006; 24: 1095103.
  • 163
    Bernardo ME, Zaffaroni N, Novara F, et al . Human bone marrow-derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res. 2007; 67: 91429.
  • 164
    Rubio D, Garcia-Castro J, Martin MC, et al . Spontaneous human adult stem cell transformation. Cancer Res. 2005; 65: 30359.
  • 165
    Lazennec G, Jorgensen C. Adult mulipotent stromal cells and cancer: risk or benefit Stem Cells. 2008; 26: 138794.
  • 166
    Maestroni GJ, Hertens E, Galli P. Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice. Cell Mol Life Sci. 1999; 55: 6637.
  • 167
    Fierro Fa, Sierralta WD, Epuñan MJ, et al . Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin Exp Metastasis. 2004; 21: 3139.
  • 168
    Gunn WG, Conley A, Deininger L, et al . A crosstalk between myeloma cells and marrow stromal cells stimulates production of Dkk1 and interleukin-6: a potential role in the development of lytic bone disease and tumor progression in multiple myeloma. Stem Cells. 2006; 24: 98691.
  • 169
    Karnoub AE, Dash AB, Vo AP, et al . Mesenchymal stem cells within tumor stroma promote breast cancer metastasis. Nature. 2007; 449: 55763.
  • 170
    Zappia E, Casazza S, Pedemonte E, et al . Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood. 2005; 106: 175561.
  • 171
    Djouad F, Fritz V, Apparailly F, et al . Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 2005; 52: 1595603.
  • 172
    Chamberlain J, Yamagami T, Colletti E, et al . Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep. Hepatology. 2007; 46: 193545.
  • 173
    Sémont A, François S, Mouiseddine M, et al . Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury. Adv Exp Med Biol. 2006; 585: 1930.
  • 174
    Herrera MB, Bussolati B, Bruno S, et al . Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med. 2004; 14: 103541.
  • 175
    Deng YB, Liu XG, Liu ZG, et al . Implantation of BM mesenchymal stem cells into injured spinal cord elicits de novo neurogenesis and functional recovery: evidence from a study in rhesus monkeys. Cytotherapy. 2006; 8: 2104.
  • 176
    Arnhold S, Absenger Y, Klein H, et al . Transplantation of bone marrow-derived mesenchymal stem cells rescue photoreceptor cells in the dystrophic retina of the rhodopsin knockout mouse. Graefes Arch Clin Exp Ophthalmol. 2007; 245: 41422.
  • 177
    Gupta N, Su X, Popov B, et al . Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol. 2007; 179: 185563.
  • 178
    Ma Y, Xu Y, Xiao Z, et al . Reconstruction of chemically burned rat corneal surface by bone marrow-derived human mesenchymal stem cells. Stem Cells. 2006; 24: 31521.
  • 179
    Xu J, Lu Y, Ding F, et al . Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-murine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene. World J Surg. 2007; 31: 187282.
  • 180
    Sun L, Cui M, Wang Z, et al . Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction. Biochem Biophys Res Commun. 2007; 357: 77984.
  • 181
    Chang W, Kim JY, Lim S, et al . Mesenchymal stem cells with calreticulin gene modulate cell adhesiveness through an integrin-mediated mechanism. Tissue Eng Regen Med. 2006; 3: 32735.
  • 182
    Dumont RJ, Dayoub H, Li JZ, et al . Ex vivo bone morphogenetic protein-9 gene therapy using human mesenchymal stem cells induces spinal fusion in rodents. Neurosurgery. 2002; 51: 123945.
  • 183
    Rabin N, Kyriakou C, Coulton L, et al . A new xenograft model of myeloma bone disease demonstrating the efficacy of human mesenchymal stem cells expressing osteoprotegerin by lentiviral gene transfer. Leukemia. 2007; 21: 218191.
  • 184
    Min C-K, Kim B-G, Park G, et al . IL-10-transduced bone marrow mesenchymal stem cells can attenuate the severity of acute graft-versus-host disease after experimental allogeneic stem cell transplantation. Bone Marrow Transplant. 2007; 39: 63745.
  • 185
    Kurozumi K, Nakamura K, Tamiya T, et al . BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol. Ther. 2004; 9: 18997.
  • 186
    Nakamura K, Ito Y, Kawano Y, et al . Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther. 2004; 11: 115564.
  • 187
    Kanehira M, Xin H, Hoshino K, et al . Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells. Cancer Gene Ther. 2007; 14: 894903.
  • 188
    Liu Y, Shu XZ, Prestwich GD. Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng. 2006; 12: 340416.
  • 189
    Syková E, Jendelová P, Urdzíková L, et al . Bone marrow stem cells and polymer hydrogels – two strategies for spinal cord injury repair. Cell Mol Neurobiol. 2006; 26: 111329.
  • 190
    Zhang J, Qi H, Wang H, et al . Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly (propylene carbonate) graft. Artif Organs. 2006; 30: 898905.
  • 191
    Tu Q, Valverde P, Li S, et al . Osterix overexpression in mesenchymal stem cells stimulates healing of critical-sized defects in murine calvarial bone. Tissue Eng. 2007; 13: 243140.
  • 192
    Hoffmann A, Pelled G, Turgeman G, et al . Neotendon formation induced by manipulation of the Smad8 signalling pathway in mesenchymal stem cells. J Clin Invest. 2006; 116: 94052.
  • 193
    Guo CA, Liu XG, Huo JZ, et al . Novel gene-modified-tissue engineering of cartilage using stable transforming growth factor-β1-transfected mesenchymal stem cells grown on chitosan scaffolds. J Biosci Bioeng. 2007; 103: 54756.
  • 194
    Mohyeddin-Bonab M, Yazdanbakhsh S, Lotfi J, et al . Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study. Iran J Immunol. 2007; 4: 5057.
  • 195
    Garcia-Olmo D, Garcia-Arranz M, Herreros D, et al . A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005; 48: 141623.
  • 196
    Kang KS, Kim SW, Oh YH, et al . A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy. 2005; 7: 36873.